BEST SPAC I Acquisition (BSAAR) Net Cash Flow (2025 - 2026)
BEST SPAC I Acquisition (BSAAR) posted quarterly Net Cash Flow of -$123420.0 for Q1 2026, down 46.87% quarter-over-quarter from -$84033.0 in Q4 2025.
Powered by 
Analysis
BEST SPAC I Acquisition (BSAAR) Net Cash Flow (2025 - 2026) Analysis & Trends
BEST SPAC I Acquisition's Net Cash Flow history runs 2 years deep, the most recent figure standing at -$123420.0 for Q1 2026.
- In Q1 2026, Net Cash Flow changed N/A year-over-year to -$123420.0; the TTM figure through Mar 2026 stood at $56.2 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, changed N/A from the prior year.
- Net Cash Flow for Q1 2026 stood at -$123420.0, down from -$84033.0 in the prior quarter.
- The five-year high for Net Cash Flow was $56.8 million in Q2 2025, with the low at -$395903.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | - |
| 3 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | -34,137.00 |
| 4 | Fifth Era Acquisition Corp I | 657.23 Mn | 657.23 Mn | - | -212,398.00 |
| 5 | Andretti Acquisition | 656.30 Mn | 656.30 Mn | - | 74,864.00 |
| 6 | Oxley Bridge Acquisition | 652.74 Mn | 652.74 Mn | - | -86,193.00 |
| 7 | Drugs Made In America Acquisition | 647.83 Mn | 647.83 Mn | - | - |
| 8 | Launch Two Acquisition | 621.00 Mn | 621.00 Mn | - | -117,520.00 |
| 9 | Launch One Acquisition | 620.42 Mn | 620.42 Mn | - | - |
| 10 | BEST SPAC I Acquisition | 417,890.00 | 417,890.00 | - | -71,127.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -71,127.00 |
| Mar 31, 2026 | -123,420.00 |
| Dec 31, 2025 | -84,033.00 |
| Sep 30, 2025 | -395,903.00 |
| Jun 30, 2025 | 56.77 Mn |